A JAKi CHAT: Shared Decision-Making in RA Sponsored by AbbVie Medical Affairs + Health Impact
Rheumnow Podcast
00:00
Balancing cancer and long-term treatment benefits
Dr. Jeff discusses cancer risk timing with JAK inhibitors and stresses weighing long-term safety against achieving remission.
Transcript
Play full episode
